check_circleStudy Completed
Menorrhagia
Bayer Identifier:
90955
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Menorrhagia study in women with treatment-resistant menorrhagia
Trial purpose
The aim of this study is to explore effects of the investigational product for the treatment of treatment-resistant menorrhagia without organic cause.
Key Participants Requirements
Sex
FemaleAge
30 - 55 YearsTrial summary
Enrollment Goal
26Trial Dates
November 2001 - January 2004Phase
Phase 2Could I Receive a placebo
YesProducts
Asoprisnil (BAY86-5294)Accepts Healthy Volunteer
NoPrimary Outcome
- Individual relative change in uterine bleeding scores by PBACdate_rangeTime Frame:Pretreatment cycle treatment phaseenhanced_encryptionNoneSafety Issue:
Secondary Outcome
- Endometrial thicknessdate_rangeTime Frame:End of treatmentenhanced_encryptionNoneSafety Issue:
- Adverse events collectiondate_rangeTime Frame:Whole treatment periodenhanced_encryptionNoneSafety Issue:
- Bleeding patterndate_rangeTime Frame:Treatment periodenhanced_encryptionNoneSafety Issue:
- Endometrial histology incl. immunohistochemical evaluationsdate_rangeTime Frame:End of treatmentenhanced_encryptionNoneSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
TreatmentAllocation
RandomizedBlinding
Double BlindAssignment
Parallel AssignmentTrial Arms
4